Atika Capital Management LLC Crispr Therapeutics Ag Call Options Transaction History

Atika Capital Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $2.79 Million - $6.06 Million	-35,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $2.75 Million - $3.52 Million	35,000 New	35,000 $2.93 Million
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $454,600 - $846,800	-20,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $852,400 - $1.47 Million	20,000 New	20,000 $1.18 Million

493

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.97B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.